Inventor
SCHUURMAN JANINE
NL54 patents
⚠️ This page may combine multiple inventors who share the name “SCHUURMAN JANINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENMAB AS
30 patentsUS7153507B2Dec 26, 2006
Human antibodies specific for interleukin 15 (IL-15)
GENMAB AS367 citations98
US7438907B2Oct 21, 2008
Human monoclonal antibodies against CD25
GENMAB AS50 citations95
US10597464B2Mar 24, 2020
Heterodimeric antibody Fc-containing proteins and methods for production thereof
GENMAB AS35 citations93
US10590206B2Mar 17, 2020
Inert format
GENMAB AS29 citations93
US10544220B2Jan 28, 2020
Bispecific antibodies against CD3 and CD20
GENMAB AS18 citations93
US10407501B2Sep 10, 2019
Humanized or chimeric CD3 antibodies
GENMAB AS15 citations93
US10344050B2Jul 9, 2019
Production of heterodimeric proteins
GENMAB AS40 citations91
US7247304B2Jul 24, 2007
Methods of treating using anti-IL-15 antibodies
GENMAB AS21 citations90
US11866514B2Jan 9, 2024
Heterodimeric antibody Fc-containing proteins and methods for production thereof
GENMAB AS5 citations85
US11485796B2Nov 1, 2022
Inert format
GENMAB AS6 citations85
US10906991B2Feb 2, 2021
Bispecific antibodies and methods for production thereof
GENMAB AS15 citations84
US9657107B2May 23, 2017
Monoclonal antibodies against c-Met
GENMAB AS9 citations84
US11492371B2Nov 8, 2022
Production of heterodimeric proteins
GENMAB AS9 citations83
US7329405B2Feb 12, 2008
Human antibodies specific for interleukin 15 (IL-15)
GENMAB AS11 citations83
US11613575B2Mar 28, 2023
Humanized or chimeric CD3 antibodies
GENMAB AS4 citations74
US11359015B2Jun 14, 2022
Humanized or chimeric CD3 antibodies
GENMAB AS6 citations74
US11046771B2Jun 29, 2021
Monoclonal antibodies against HER2
GENMAB AS2 citations72
US10351629B2Jul 16, 2019
Recombinant IgG4 monovalent antibodies
GENMAB AS2 citations72
US9598493B2Mar 21, 2017
Human monoclonal antibodies against CD25
GENMAB AS3 citations72
US7585961B2Sep 8, 2009
Nucleic acid encoding human antibodies specific for interleukin 15 (IL-15)
GENMAB AS5 citations72
US11578141B2Feb 14, 2023
Bispecific antibodies against HER2 and CD3
GENMAB AS1 citations62
US11512140B2Nov 29, 2022
Monoclonal antibodies against c-Met
GENMAB AS0 citations62
US12247065B2Mar 11, 2025
Method for producing a controlled mixture of two or more different antibodies
GENMAB AS1 citations61
US11091553B2Aug 17, 2021
Monoclonal antibodies against HER2
GENMAB AS1 citations61
US7597892B2Oct 6, 2009
Method for treating psoriasis by administering human antibodies specific for Interleukin 15 (IL-15)
GENMAB AS1 citations61
US10752695B2Aug 25, 2020
Stable IgG4 antibodies
GENMAB AS1 citations60
US10865253B2Dec 15, 2020
Rodent bispecific heterodimeric proteins
GENMAB AS1 citations57
US12595316B2Apr 7, 2026
Bispecific and multispecific antibodies and method for isolation of such
GENMAB AS0 citations55
US10703818B2Jul 7, 2020
Human monoclonal antibodies against CD25
GENMAB AS0 citations51
US10000570B2Jun 19, 2018
Antibody variants having modifications in the constant region
GENMAB AS1 citations51
GENMAB BV
6 patentsUS12049512B2Jul 30, 2024
Antibody variants and uses thereof
GENMAB BV5 citations85
US11180572B2Nov 23, 2021
Dimeric protein with triple mutations
GENMAB BV12 citations83
US10882913B2Jan 5, 2021
Anti-DR5 antibodies and methods of use thereof
GENMAB BV4 citations71
US12247080B2Mar 11, 2025
Anti-DR5 antibodies and methods of use thereof
GENMAB BV0 citations60
US12338289B2Jun 24, 2025
Antibody variant combinations and uses thereof
GENMAB BV0 citations58
US12173076B2Dec 24, 2024
Polypeptide variants and uses thereof
GENMAB BV1 citations57
SCHUURMAN JANINE
4 patentsUS9212230B2Dec 15, 2015
Bispecific antibodies and methods for production thereof
SCHUURMAN JANINE54 citations95
US8961968B2Feb 24, 2015
Human monoclonal antibodies against CD25
SCHUURMAN JANINE5 citations82
US8182812B2May 22, 2012
Human monoclonal antibodies against CD25
SCHUURMAN JANINE7 citations82
US9322035B2Apr 26, 2016
Recombinant IgG4 monovalent antibodies
SCHUURMAN JANINE2 citations61
JANSSEN BIOTECH INC
4 patentsUS9593164B2Mar 14, 2017
Bispecific EGFR/c-Met antibodies
JANSSEN BIOTECH INC34 citations93
US9580508B2Feb 28, 2017
Bispecific EGFR/c-Met antibodies
JANSSEN BIOTECH INC19 citations91
US9695242B2Jul 4, 2017
Bispecific EGFR/c-Met antibodies
JANSSEN BIOTECH INC8 citations83
US12247077B2Mar 11, 2025
Bispecific EGFR/c-Met antibodies
JANSSEN BIOTECH INC0 citations51
LABRIJN ARAN FRANK
2 patentsGENMAB
1 patentDE GOEIJ BART
1 patentPARREN PAUL
1 patentNEIJSSEN JOOST J
1 patentShowing the top 50 of 54 patents by PatentIndex Score.